Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Study of Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis

ClinicalTrials.gov ID: NCT02029495

Public ClinicalTrials.gov record NCT02029495. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 5:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to evaluate the efficacy of brodalumab, compared to placebo, in subjects with psoriatic arthritis.

Study identification

NCT ID
NCT02029495
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bausch Health Americas, Inc.
Industry
Enrollment
478 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2014 (Type not available)
Primary completion
Oct 2015 (Actual)
Completion
Oct 2015 (Actual)
Last update posted
May 19, 2017

2014 – 2015

United States locations

U.S. sites
43
U.S. states
25
U.S. cities
43
Facility City State ZIP Site status
Research Site Huntsville Alabama 35801 —
Research Site Tuscaloosa Alabama 35406 —
Research Site Peoria Arizona 85381 —
Research Site Scottsdale Arizona 85258 —
Research Site Los Angeles California 90095 —
Research Site Mather California 95655 —
Research Site Murrieta California 92563 —
Research Site Palm Desert California 92260 —
Research Site Tustin California 92780 —
Research Site Upland California 91786 —
Research Site Jupiter Florida 33458 —
Research Site Tamarac Florida 33321 —
Research Site Tampa Florida 33613 —
Research Site Gainesville Georgia 30501 —
Research Site Meridian Idaho 83642 —
Research Site Springfield Illinois 62703 —
Research Site Bowling Green Kentucky 42101 —
Research Site Somerset Kentucky 42503 —
Research Site Frederick Maryland 21702 —
Research Site Wheaton Maryland 20902 —
Research Site Worcester Massachusetts 01605 —
Research Site Lansing Michigan 48910 —
Research Site Eagan Minnesota 55121 —
Research Site Omaha Nebraska 68114 —
Research Site Clifton New Jersey 07012 —
Research Site Great Neck New York 11021 —
Research Site Lake Success New York 11042 —
Research Site New York New York 10016 —
Research Site Plainview New York 11803 —
Research Site Asheville North Carolina 28803 —
Research Site Bend Oregon 97701 —
Research Site Portland Oregon 97239 —
Research Site Duncansville Pennsylvania 16635 —
Research Site Charleston South Carolina 29406 —
Research Site Hixson Tennessee 37343 —
Research Site Austin Texas 78731 —
Research Site Houston Texas 77074 —
Research Site San Antonio Texas 78232 —
Research Site Danville Virginia 24541 —
Research Site Seattle Washington 98104 —
Research Site Beckley West Virginia 25801 —
Research Site Bridgeport West Virginia 26330 —
Research Site Glendale Wisconsin 53217 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 109 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02029495, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 19, 2017 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02029495 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →